ACKNOWLEDGEMENTS This project was funded in part by the Telligen Community Initiative to initiate and support, through research and programs, innovative and farsighted health-related projects aimed at improving the health, social well-being and educational attainment of society, where such needs are expressed. Special thanks to the Oklahoma Pediatric Psychotropic Medication Resource Guide Taskforce and the following individuals for their peer review and feedback of this module:
Task-Force Members Core Team: Co-Chair Sara Coffey, D.O. Assistant Clinical Professor, Director of Child and Adolescent Psychiatry Oklahoma State University Center for Health Sciences Director Clinical Operations Department of Human Services Division of Child Welfare Co-Chair Brent Bell, D.O. Physician Consultant Oklahoma Health Care Authority Jill Ratterman, D.Ph. Clinical Pharmacist Oklahoma Health Care Authority
Task-Force Members: Michyla Adams, Pharm.D. Clinical Pharmacist OUHSC College of Pharmacy Pharmacy Management Consultants Tara R. Buck, M.D. Associate Professor, Associate Program Director Child & Adolescent Psychiatry Fellowship Oxley Foundation Chair in Child and Adolescent Psychiatric Research Department of Psychiatry University of Oklahoma School of Community Medicine Tessa Chesher, D.O. Associate Clinical Professor Child and Adolescent Psychiatry Department of Psychiatry and Behavioral Sciences Oklahoma State University Center for Health Sciences
M E D I C I N E . O K S T A T E . E D U
117
